Concert Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.33M

  • Investors
  • 17

Concert Bio General Information

Description

Provider of biological systems intended for optimizing crop performance in controlled environments. The company's platform leverages advanced data science and a proprietary microbiome database to identify and supply beneficial microbes for hydroponic growers, utilizing DNA sequencing to analyze both pathogens and beneficial species, providing all necessary sampling equipment, and offering ongoing expert support through regular consultations; this enables greenhouse agriculture operators to enhance crop yield, quality, and resilience by recreating and optimizing the plant microbiome in hydroponic systems.

Contact Information

Website
www.concert.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 134O, Translation And Innovation Hub
  • 84 Wood Lane
  • London W12 0BZ
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Business/Productivity Software
Corporate Office
  • 134O, Translation And Innovation Hub
  • 84 Wood Lane
  • London W12 0BZ
  • England, United Kingdom

Concert Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Concert Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 25-Oct-2024 $1.33M Completed Generating Revenue
6. Early Stage VC 05-Apr-2024 Completed Generating Revenue
5. Accelerator/Incubator 28-Mar-2024 Completed Generating Revenue
4. Grant 01-Dec-2022 Completed Generating Revenue
3. Seed Round 08-Apr-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Concert Bio’s complete valuation and funding history, request access »

Concert Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 7,353 $0.000127 $3.27 $3.27 1x $3.27 0.68%
To view Concert Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Concert Bio Patents

Concert Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202407617-D0 Microbial composition for enhancing plant growth Inactive 03-Jun-2024
GB-202407625-D0 Microbial composition for enhancing plant growth Inactive 03-Jun-2024
WO-2025248067-A1 Microbial composition for enhancing plant growth Pending 28-May-2024
WO-2025252597-A1 Microbial composition for enhancing plant growth Pending 28-May-2024 C12N1/205

Concert Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concert Bio Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arcas Ventures Venture Capital Minority
EQT Foundation Impact Investing Minority
Waterpoint Lane Venture Capital Minority
StartLife Accelerator/Incubator
Innovate UK Government
You’re viewing 5 of 17 investors. Get the full list »

Concert Bio FAQs

  • When was Concert Bio founded?

    Concert Bio was founded in 2021.

  • Where is Concert Bio headquartered?

    Concert Bio is headquartered in London, United Kingdom.

  • What is the size of Concert Bio?

    Concert Bio has 13 total employees.

  • What industry is Concert Bio in?

    Concert Bio’s primary industry is Biotechnology.

  • Is Concert Bio a private or public company?

    Concert Bio is a Private company.

  • What is Concert Bio’s current revenue?

    The current revenue for Concert Bio is .

  • How much funding has Concert Bio raised over time?

    Concert Bio has raised $2.11M.

  • Who are Concert Bio’s investors?

    Arcas Ventures, EQT Foundation, Waterpoint Lane, StartLife, and Innovate UK are 5 of 17 investors who have invested in Concert Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process